Inspira Technologies' Innovative Life-Support System to be Showcased at AmSECT 63rd International Conference 2025 in San Diego

Core Insights - Inspira Technologies will showcase its FDA-cleared INSPIRA ART100 cardiopulmonary bypass system at the AmSECT 63rd International Conference from March 19-23, 2025, in San Diego, California [1][2][3] Company Overview - Inspira Technologies is focused on developing innovative life-support and diagnostic technologies, with the INSPIRA ART100 system being a significant advancement in extracorporeal circulation technology [1][5] - The INSPIRA ART100 received FDA 510(k) clearance in May 2024 for use in cardiopulmonary bypass procedures and has also received regulatory approvals in Israel for similar applications [2][5] Industry Context - The AmSECT International Conference is a premier global event for perfusion professionals, emphasizing advancements in extracorporeal circulation, patient care, and perfusion education [4] - The conference provides a platform for showcasing the latest medical technologies and research that shape the future of perfusion [4]